Diabetes 2 and Stage 3 Renal Insufficiency - TuDiabetes

Links shared publicly online about this topic.

907
total visits

Diabetes 2 and Stage 3 Renal Insufficiency - TuDiabetes

When I look for recommendations for diet for type 2 and for renal insufficiency, what's good for one seems to be bad for the other and vice versa. I throw my hands up and just think - cook common sense healthy. But are there good resources about diet or recipesfor people with both conditions?

View full resource at tudiabetes.org

Tags: Diabetes, Kidney Health, Urinary System, Kidney Failure, Diet and Nutrition, Cooking

Most Recently Shared on August 31, 2010 at 5:08 pm By:

a diabetes community

Food + #diabetes: Diabetes 2 and Stage 3 Renal Insufficiency: When I look for recommendations for diet for type 2 ... http://bit.ly/cdUYJI

2 years ago...

Retweet

Favorite

Anemia FAQs of Symptoms, Causes, Diagnosis and Treatment | NAAC National Anemia Action Council

anemia.org — “National Anemia Action Council NAAC offers patient resource information guide and research studies on anemia, anemic symptoms / anemia symptoms, anemic treatment / anemia treatment; also includes information on iron deficiency, low hemoglobin, low hematocrit, anemia treatment and anemia symptoms associated with chronic diseases such as chronic renal insufficiency (CRI), end stage renal disease (ESRD), chronic kidney disease (CKD), diabetes, HIV, cardiovascular disease (CVD), rheumatoid arthritis” View full resource at anemia.org

Most Recently Shared on December 5, 2010 at 2:27 am By:

Dr. Susan Beck Acupuncturist, Doctor, CAM, Nutritionist, and PhD

December brings National #Anemia Awareness Month. See here for helpful information on this medical condition. http://ow.ly/3k3MD

1 year ago...

Retweet

Favorite

ESA Risks, Benefits Highlighted By TREAT Study in Pre-Dialysis Patients | Research Review | NAAC National Anemia Action Council

anemia.org — “Although the benefit of erythropoiesis-stimulating agents (ESAs) has long been assumed, investigators do not know whether an increase of hemoglobin (Hb) levels through the use of ESAs will lower the risk for cardiovascular events and end-stage renal disease. The Trial to Reduce Cardiovascular Events with Aranesp therapy (TREAT) was designed to test this hypothesis in patients with type 2 diabetes, chronic kidney disease, and anemia who were not on dialysis. Unique in its comparison of an ESA to ” View full resource at anemia.org